Literature DB >> 33809336

Identification of Breast Cancer Subtype-Specific Biomarkers by Integrating Copy Number Alterations and Gene Expression Profiles.

Claudia Cava1, Mirko Pisati1,2, Marco Frasca2, Isabella Castiglioni3.   

Abstract

Background and
Objectives: Breast cancer is a heterogeneous disease categorized into four subtypes. Previous studies have shown that copy number alterations of several genes are implicated with the development and progression of many cancers. This study evaluates the effects of DNA copy number alterations on gene expression levels in different breast cancer subtypes. Materials and
Methods: We performed a computational analysis integrating copy number alterations and gene expression profiles in 1024 breast cancer samples grouped into four molecular subtypes: luminal A, luminal B, HER2, and basal.
Results: Our analyses identified several genes correlated in all subtypes such as KIAA1967 and MCPH1. In addition, several subtype-specific genes that showed a significant correlation between copy number and gene expression profiles were detected: SMARCB1, AZIN1, MTDH in luminal A, PPP2R5E, APEX1, GCN5 in luminal B, TNFAIP1, PCYT2, DIABLO in HER2, and FAM175B, SENP5, SCAF1 in basal subtype. Conclusions: This study showed that computational analyses integrating copy number and gene expression can contribute to unveil the molecular mechanisms of cancer and identify new subtype-specific biomarkers.

Entities:  

Keywords:  breast cancer subtypes; copy number alteration; gene expression

Year:  2021        PMID: 33809336      PMCID: PMC7998437          DOI: 10.3390/medicina57030261

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  52 in total

1.  Combination of gene expression and genome copy number alteration has a prognostic value for breast cancer.

Authors:  C Cava; I Zoppis; G Mauri; M Ripamonti; F Gallivanone; C Salvatore; M C Gilardi; I Castiglioni
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

2.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

3.  Tissue-Specific Signaling Networks Rewired by Major Somatic Mutations in Human Cancer Revealed by Proteome-Wide Discovery.

Authors:  Junfei Zhao; Feixiong Cheng; Zhongming Zhao
Journal:  Cancer Res       Date:  2017-03-31       Impact factor: 12.701

4.  Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma.

Authors:  Changcan Li; Jianhua Liao; Shaohan Wu; Junwei Fan; Zhihai Peng; Zhaowen Wang
Journal:  Biochem Biophys Res Commun       Date:  2017-10-26       Impact factor: 3.575

5.  Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference.

Authors:  Claudia Cava; Italo Zoppis; Manuela Gariboldi; Isabella Castiglioni; Giancarlo Mauri; Marco Antoniotti
Journal:  J Clin Bioinforma       Date:  2014-01-24

6.  Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly.

Authors:  Anna Tervasmäki; Tuomo Mantere; Leila Eshraghi; Niina Laurila; Hanna Tuppurainen; Veli-Pekka Ronkainen; Susanna Koivuluoma; Raman Devarajan; Hellevi Peltoketo; Katri Pylkäs
Journal:  Int J Cancer       Date:  2019-03-21       Impact factor: 7.396

7.  Transcriptional effects of copy number alterations in a large set of human cancers.

Authors:  Arkajyoti Bhattacharya; Rico D Bense; Carlos G Urzúa-Traslaviña; Elisabeth G E de Vries; Marcel A T M van Vugt; Rudolf S N Fehrmann
Journal:  Nat Commun       Date:  2020-02-05       Impact factor: 14.919

8.  Integrating mutation and gene expression cross-sectional data to infer cancer progression.

Authors:  Julia L Fleck; Ana B Pavel; Christos G Cassandras
Journal:  BMC Syst Biol       Date:  2016-01-25

9.  Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes.

Authors:  Zhilei Zhao; Seiichiro Jinde; Shinsuke Koike; Mariko Tada; Yoshihiro Satomura; Akane Yoshikawa; Yukika Nishimura; Ryu Takizawa; Akihide Kinoshita; Eisuke Sakakibara; Hanako Sakurada; Mika Yamagishi; Fumichika Nishimura; Aya Inai; Masaki Nishioka; Yosuke Eriguchi; Tsuyoshi Araki; Atsuhiko Takaya; Chiemi Kan; Maki Umeda; Akihito Shimazu; Hideki Hashimoto; Miki Bundo; Kazuya Iwamoto; Chihiro Kakiuchi; Kiyoto Kasai
Journal:  Transl Psychiatry       Date:  2019-11-11       Impact factor: 6.222

View more
  3 in total

Review 1.  Bilayer Forming Phospholipids as Targets for Cancer Therapy.

Authors:  Celine Stoica; Adilson Kleber Ferreira; Kayleigh Hannan; Marica Bakovic
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

2.  Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.

Authors:  Lingyu Li; Zhi-Ping Liu
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

3.  Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer.

Authors:  Zainab Al-Taie; Mark Hannink; Jonathan Mitchem; Christos Papageorgiou; Chi-Ren Shyu
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.